Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DLAT - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
VDAC3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SUN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PSMA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RNF38 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC25A3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
POLR2B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
IREB2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARL8B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAPZA2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DYNC2LI1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP5C1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
KLHDC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SCFD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
VTA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CLTC - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RHEB - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DDX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on